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susceptibility of Streptococcus pneumoniae to 
benzylpenicillin, arnoxicillin and cefotaxirne 
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Laboratoire de  Microbiologie, CHU Brest, Brest, and 2Laboratoires de  Microbiologie des HBpitaux 
de  Auray, Dinan, Foug&res, Guinguanip, Lannion, Lorient, Paimpol, Quimper,  Rennes,  St Brieuc, 
Vannes, France 
Objective: To study the routine use of the E-test for susceptibility testing of penicillin-resistant Streptococcus 
pneurnoniae. 
Methods: A multicenter study of penicillin-resistant S. pneurnoniae (PRSP) was carried out in  Brittany, France (10 
general hospitals, and two university hospitals including a coordinating center). Each hospital detected PRSP by the 
oxacillin (5-yg) disk method and determined the MlCs of penicillin G, amoxicillin and cefotaxime by the E-test under 
routine conditions. All the PRSP strains were collected in a coordinating center and the MlCs were checked by the agar 
dilution method. The classifications obtained from the MlCs determined by the E-test and by the reference method were 
compared. 
Results: Between 1 July 1993 and 30 June 1994, 128 PRSP strains were collected. Agreement within 1 log2 dilution was 
obtained for only 62% of strains with benzylpenicillin, 72.5% with amoxicillin and 76% with cefotaxime. These data are 
well below published values. In addition, 52% of the strains found to be penicillin-resistant by the reference technique 
were of intermediate resistance according to  the E-test. There were major differences in the quality of the results 
obtained by the participating laboratories. 
Conclusions: There are problems of standardization in the routine use of the E-test. Microbiologists should therefore 
take particular care when performing the test and when reading the results, and ensure that reference strains are 
included in  the assay. 
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INTRODUCTION 
Pneumococci have become considerably more resistant 
to benzylpenicillin in recent years [l-51, and 25.1% of 
the isolates tested in France in 1993 were resistant t o  
this antibiotic [6].  This has led to clinical problems in 
the treatment ofmeningitis and acute otitis [7-111. The 
degree of resistance demonstrated depends upon the 
specific p-lactam used, and it is the high resistance of 
some strains that is mainly responsible for treatment 
failures [9,12]. In addition, although third-generation 
cephalosporins may be indicated in the most severe 
disorders, the development of strains that are highly 
resistant to these molecules can jeopardize their effect- 
iveness [7,13,14]. 
It  is therefore important to specify the degree of 
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resistance of the strain by determining the minimal 
inhibitory concentrations (MICs) of individual relevant 
antibiotics. The technique used should be reliable, easy 
to perform, rapid and reproducible. Several studies have 
shown that the E-test (AB Biodisk, Solna, Sweden) 
fulfills these requirements and appears to be suitable 
for determining the MICs of p-lactams for Strepto- 
coccus pneumoniae [ 15-1 91. Hence this technique is 
now routinely used in many diagnostic laboratories. 
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However, the widespread use of the test raises problenis 
of inter-laboratory standardization and requires re- 
examination of the reliability of the test under these 
new conditions of use. 
This study was therefore carried out to compare 
the MICs obtained with the E-test used under routine 
conditions in 12 hospital laboratories in Brittany, 
France, with those obtained by a reference technique 
of agar dilution performed in a single coordinating 
laboratory. The results indicate that the E-test is not as 
effective under routine conditions as in the controlled 
trials carried out in reference centers, and that its use 
may lead to errors of classification. 
MATERIALS AND METHODS 
Strains of pneumococci with reduced susceptibility to 
penicillins (penicillin-resistant Streptococcus pneurnoniae: 
PRSP) were detected in 12 hospital laboratories in 
Brittany, two university hospitals (Brest and Kennes) 
and 10 general hospitals (Auray, Dinan, Foughres, 
Guingamp, Laniiion, Lorient, Painipol, Quimper, St 
Brieuc and Vannes) between 1 July 1993 and 30 June 
1994. The PKSP strains were screened with a 5-pg 
oxacillin disk 1201. A diameter of <25 mm was taken 
to indicate a PRSP isolate. The MICs of benzyl- 
penicillin, amoxicillin and cefotaxime were then deter- 
mined for each of these strains by the E-test in 
all the participating laboratories. The manufacturer's 
instructions are shown in  Table 1. 'The tests were 
routinely performed in all laboratories, as shown in 
Table 1. 
All the PRSP strains were collected in a coordina- 
ting center and the MICs were checked by the 
reference method of agar dilution [21]. Doubling 
dilutions were prepared in Mueller-Hinton agar (Sanofi 
Diagnostics Pasteur, Marnes-la-Coquette, France) sup- 
plemented with 5% horseblood (Bioiiikrieux, Marcy 
l'Etoile, France). The inoculuni was prepared from a n  
18-h culture resuspended in brain-heart infusion broth 
(BioniPrieux, Marcy l'Etoile, France) supplemented 
with ascites fluid (Pasteur, Marnes-la-Coquette, France) 
and grown at 37°C under agitation for 3 h to a 0.5 
McFarland turbidity standard. The resulting suspension 
was deposited with a Steers plater, depositing 1 pL 
containing approximately I O4 colony-forming units. 
The plates were incubated at 37 "C in 5% COn for 18 11. 
A set of five strains of known MIC, provided by the 
Centre National de Reference des Pneumocoques 
(CNRP), was included in the tests. 
The strains were classified as susceptible, inter- 
mediate and resistant according to the ComitC de 
1'Antibiogramme de la SociPtC Franqaise de Micro- 
biologie (CASFM) (221. Those strains having MICs 
50.06 pg/mL for benzylpenicillin and amoxicillin were 
considered to be susceptible, those with MICs 0.1- 
1 pg/mL intermediate, and those MICs 2 2  pg/niL 
resistant. The equivalent MICs for cefotaxinie were 
10.5 pg/niL (susceptible), 1-2 pg/niL (intermediate) 
and >2 pg/mL (resistant). The classifications obtained 
from the MIC determined by the E-test and by the 
reference technique were compared. Since the E-test 
has half instead of full two-fold dilutions, MICs 
obtained with the E-test were rounded to the next 
higher log? dilution if the MIC fell between the 
standard two-fold increments of the reference method. 
Additionally, in order to verify that the dis- 
crepancies resulted from inter-center variations, the 
MICs of 10 selected strains, showing a difference by the 
two techniques 2 +2 log? dilutions for benzylpenicillin, 
were checked by the C N R P  by the reference method. 
The E-tests for benzylpenicillin were also checked by 
the coordinating center for 33 strains taken at random 
Table 1 
Chiter Medium Atmosphere" Inoculum" Inoculation 
Etest conditions prescribed by the manufacturer and used in the participating centers 
Swabbing MCmiifacturer MH' + 5% horse co* 0.5 
A MH/Sheep coz 0.5 Flooding 
B MH/Hone Aerobic 0.5 Swabbing 
1) MH/Sheep coz 1 Flooding 
E MH/Shrep COa 0.5 Swabbing 
F MH/Horse Anaerobic 1 Flooding 
c; MHIHorse co2 0.5 Floodirig 
H MHISheep c o z  0.5 Swabbing 
'Incubated at 37OC for 18 h for all participating centcrs. 
hExpreascd in McFarland turbidity 
'MH: Muellrr-Hinton agar. 
or Fhrep blood 
c MH/Horse co2 0.5 Swabhlng 
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from those showing a difference between the E-test and 
the reference test of 2?1 log2 dilution. 
RESULTS 
In total, 128 PRSP strains were sent to the coordinating 
center between 1 July 1993 and 30 June 1994 by 
eight of the 12 participating hospitals. The MICs of 
benzylpenicillin for 121 strains, of amoxicillin for 120 
strains and of cefotaxime for 119 strains were compared 
by the two methods. The MICs obtained by the 
two methods were used to classitji the strains into 
susceptible, intermediate and resistant according to the 
CASFM criteria (Table 2). The MICs obtained by the 
E-test were compared to those obtained by the reference 
test (Table 3). The MICs were in agreement within 
+1 log2 dilution for benzylpenicillin in 75/121 strains 
(62%), in 87/120 strains (72.5%) for amoxicillin, and 
Table 2 Susceptibility determined by the Etest and agar 
dilution methods 
in 90/119 strains (76%) for cefotaxime. Statistically 
significant differences in the level of discrepancy 
between the two techniques were shown among the 
individual centers (r, < lop3) (Table 4). For example, 
the MICs obtained in center D were in agreement for 
penicillin in 100% of strains, whereas the percentage 
agreement was 20% in center C. 
These differences resulted in many strains being 
classified as susceptible, intermediate or resistant 
differently, depending on the method used to measure 
the MIC. The classification based on the MIC obtained 
by the E-test was in agreement with that based on the 
MIC obtained by the reference test for only 661121 
strains (54.5%) tested for benzylpenicillin. The agree- 
ments were a little better for amoxicillin (62% of strains) 
and cefotaxime (68%). Most of the minor errors 
for benzylpenicillin and amoxicillin occurred around 
the breakpoint separating intermediate and resistant 
strains. Because the MICs for cefotaxime were some- 
what lower, these minor errors occurred around the 
threshold between intermediate and susceptible strains. 
Number of isolates assayed by agar dilution as: 
E-test result 
(no. of isolates tested) Susceptible Intermediate Resistant 
Benzylpenicillin (1 2 1) 
Susceptible 0 0 0 
Intermediate 2 18 52 
Resistant 0 1 48 
Amoxicillin (120) 
Susceptible 11 1 (1 
Intermediate 2 47 38 
Resistant 0 4 17 
Cefotaxime (1 19) 
Susceptible 42 25 0 
Intermediate 9 39 0 
Resistant 0 4 0 
Table 3 Comparison of MICs determined by the Etest and 
agar dilution 
Number of isolates with the 
following differences in MIC:" 
Antimicrobial agent <-2 -2 -1 0 +1 +2  > + 2  
Benzylpenicillin 17 26 32 36 7 2 1 
(121 strains) 
Amoxicillin 11 21 39 34 14 0 1 
(120 strains) 
Cefotaxime 4 15 32 31 27 9 1 
(119 strains) 
aZero indicates number of isolates for which MICs are identical; 
-1 and +I indicate 21 log2 dilution difference, etc. 
Table 4 Agreement between benzylpenicillin MICs determined by Etest and the reference method, for the eight 
participating centers 
Number of isolates with Etest results showing indicated number of 
doubling dilutions either above or below the reference method MIC value 
Percentage 
Center <-2 -2 -1 0 1 2 > + 2  agreement (%)a 
1 
2 
3 
8 
10 
2 
- 
8 
~ 
23 
2 
- 
1 
1 
~ 
89.5 
N A ~  
20 
100 
76 
23.5 
27 
71.5 
~~~~~~~~~~~ 
"Agreement: % of strains with a mfference in MICs I k 1  log2 
hNA not applicable because not enough strams 
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The MICs checked by the CNKP for the 10 strains 
for which the difference between the two techniques 
was 2?2 log2 dilutions for benzylpenicillin were all 
within +1  log2 dilution of the MICs determined by 
the reference method by the coordinating center, for all 
three antibiotics tested (data not shown). The E-tests 
for benzylpenicillin were checked by the coordinating 
center on 33 strains having a difference between the E- 
test and reference method values of 2: l log? dilution. 
They were within f l  log2 dilution of the MICs 
obtained by the reference technique (data not shown). 
DISCUSSION 
The development of PKSP and the therapeutic 
problems that have been reported dut. to these strains 
niake it imperative to carry out a precise in vitro study 
of their sensitivity to p-lactam agents. This work was 
done using the E-test, which provides overnight results 
and which is easier to perform than agar dilution. But 
this test must be performed with great care and the 
results carefully read to avoid the errors identified in this 
study. 
Reduced susceptibility to penicillin is presently 
detected using disks loaded with 1 pg or 5 pg oxacillin. 
This is an inexpensive, simple method, but it only 
provides qualitative results that cannot be used to 
distinguish between resistant strains and intermediate 
strains. However, this level of resistance must be 
known, because treatment failures have been linked to 
it [9,12,23]. Neither can the activity ofbenzylpenicillin 
be used to predict the activities of other p-lactam 
agents. While all p-lactani agents have reduced activity 
against PRSP strains, some niolecules are relatively 
more active [24], and cephalosporin disks cannot be 
used to reliably detect resistance to these molecules 
1251. Lastly, some reports indicate that oxacillin disks 
can indicate false resistance [26,27], and strains resistant 
to oxacillin but susceptible to benzylpenicillin have 
recently been found [28,29]. Only two of the 121 
strains tested for susceptibility to benzylpenicillin in 
the present study showed reduced susceptibility by the 
oxacillin disk test but were susceptible to benzyl- 
penicillin in the reference test. 
It is therefore necessary to determine the MICs 
of p-lactam agents that are likely to be used clinically. 
The agar dilution technique is the reference method 
[21], but it is difficult to set up, time-consuming 
and expensive, especially when several antibiotics must 
be tested on a single strain. The broth niicrodilution 
niethod [30] is an alternative, but is equally expen- 
sive and delicate. These two techniques are used by 
reference laboratories and are rarely implemented in 
routine testing in clinical bacteriology laboratories. 
The E-test is a new alternative to the above methods 
that makes the determination of MIC simple arid 
within the reach of all laboratories. The technique has 
been shown to be reproducible for pneumococci 1191 
and to provide reliable MIC data [15,17,18,31]. The 
present study shows that all the 33 MIC values for 
benzylpenicillin determined by the E-test and checked 
by the coordinating center agreed with the reference 
test value within f 1 log2 dilution, despite the fact that 
27 of the strains differed by 2?2 log? dilutions from 
the reference value during the initial routine deter- 
minations in the 12 hospitals. The checks carried out 
by the C N R P  and the coordinating center show that 
the E-test provides reliable results. But there were major 
differences in the results obtained by the participating 
laboratories. This indicates that there are problems of 
standardization in running the test. Others have 
reported similar difficulties. Spicq found that only 77% 
of isolates had MICs within 2 1 log2 dilution between 
E-test and reference test in routine use, compared to 
90-1 00% in controlled trials [32]. The conditions 
under which the E-test were performed varied greatly, 
and no conclusion can be drawn as to which technique 
should be used. Bolmstriini has shown recently that 
there were no differences when horse blood or sheep 
blood were used in the medium, but the use of COz 
during incubation could produce lower MIC value? 
by a single dilution [33]. Plate reading is particularly 
critical, as the zone of complete inhibition is difficult 
to determine in the presence of microcolonies and a- 
hemolysis. This is probably why the results of centers 
A and G were very different (Table 4), even though the 
inocula were the same and the techniques used were 
identical (Table 1). 
Most (32/33) of the MICs determined by the 
controlled E-test in this study were the same as or one 
dilution under the values given by the reference test; 
similar results have been obtained by others [15,16,34], 
indicating that the E-test underestimates the MICs of 
p-lactani agents for PRSP. This underestimation of the 
MIC, especially around the critical threshold, resulted 
in underestimation of the resistance of several strains 
(Table 3). Scheel found that 10 of the 16 strains 
classified as resistant by the reference method were 
placed in the intermediate category by the E-test [35]. 
This situation, which could cause problenis when 
selecting a specific antibiotic for treatment, led Scheel 
to suggest changing the critical values for determining 
the susceptibility to benzylpenicillin by the E-test [351. 
Only clinical studies can indicate the practical inipor- 
tame of these laboratory observations. 
The present study is in agreement with published 
data indicating that the E-test is a good test for rapidly 
and reliably evaluating the sensitivity of several strains 
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of S. pneumonine to one or more antibiotics. However, 
it has revealed problems in the performance of the test 
and reading the results when used in the routine 
laboratory. Inoculation, Petri dish drying and incuba- 
tion are among the steps that must be standardized in 
all laboratories in order to obtain satisfactory E-tests. 
The E-test strips must be stored correctly The system 
should use horse blood or sheep blood agar and plating 
with an inoculum with an opacity of 0.5 McFarland by 
swabbing or, after 100-fold dilution, by flooding. Plates 
should be incubated with COz and read carefully. 
Reference strains with different MICs should be tested 
at the same time. With these precautions, the E-test is 
a method suitable for determining the resistance to 
p-lactam agents of strains of pneumococci. This, in 
turn, will lead to the correct guidance of clinicians in 
their prescription of an effective antibiotic. 
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